New Findings in Anti-Obesity Medications | ENDO 2022 Research Highlights

Obesity Research | ENDO 2022 HighlightsПодробнее

Benefits of Weight Loss | ENDO 2022 HighlightsПодробнее

Education on Obesity | ENDO 2022 HighlightsПодробнее

Concerns Around Compounding Anti-Obesity MedicationsПодробнее

Obesity Treatments for a Chronic Condition | ENDO 2022 HighlightsПодробнее

Underutilized Medications | ENDO 2022 HighlightsПодробнее

Barriers to Obesity | ENDO 2022 HighlightsПодробнее

Obesity | ENDO 2022 Press ConferenceПодробнее

ENDO 2021 Press Conference: ObesityПодробнее

Thyroid | ENDO 2022 Press ConferenceПодробнее

Obesity | ENDO 2020 Virtual News ConferenceПодробнее

World Anti-Obesity Day | KIMS HospitalsПодробнее

Weight loss drugs are 'huge market' for pharmaceuticals: AnalystПодробнее

New Advances in Obesity Management but Challenges RemainПодробнее

EFL045 - Long-Term Effects of Anti-Obesity MedicationsПодробнее

Studies Show New Weight Loss Medications are the Real DealПодробнее

Shocking Side Effect of Weight Loss Medication Revealed #semaglutide #research #weightloss #ozempicПодробнее

Obesity Drug Survey: Longer Treatment, More Money MadeПодробнее